It's being conducted at Northwestern University's Feinberg School of Medicine in Chicago and involves turning off the body's allergic response by attaching peanut proteins onto blood cells. Those cells are then reintroduced, tricking the immune system into thinking the proteins pose no threat.
Several hundred Americans die each year due to peanut allergies. The next step in the research is human trials, but that could be years away.
